Adtheorent SPAC Presentation Deck

Proven Ability to Land and Expand Into New Verticals and with Blue Chip Clients · ● We will continue to scale Healthcare/Pharma (AdTheorentRX) and Banking, Financial Services and Insurance (BFSI) solutions, capitalizing on unique advantages related to AdTheorent privacy-friendly data practices and targeting/ modeling protocols which comply with industry regulations and brand model governance Dedicated Vertical Solutions Team will deliver more unique solutions to expand growing verticals: Auto - first to market Audience Validation solution and proprietary Keyword RTS Targeting Entertainment - suite of products featuring ACR/Viewership data and measurement integrations CPG - SKU level sales lift solution; sales data powering ML model optimizations Total Spend by Vertical 2017 2018 ● 2015 Confidential | Page 27 2016 CAGR: 74% Healthcare/Pharma 2019 CAGR: 48% 2020 BFSI 2021 P CAGR: 429% Finance Client #1 Demonstrated Revenue Growth 2018 ADTHEORENT 2019 ■2020 CAGR: 322% Pharmaceutical Client #1 CAGR: 107% Finance Client #2 Recent Wins Coca-Cola Edward Jones gsk M. P&G Staples. Why Are More Brands Expanding With AdTheorent? 1. AdTheorent Delivers Measurable Value 2. AdTheorent Addresses Tough KPIs 3. AdTheorent Has a Wide Range of Verticalized Solutions

View entire presentation